Studies in dissolution enhancement of ezetimibe by solid dispersions in combination with a surface adsorbent

Dissolution Technologies

Volumn 18, Issue 3, 2011, Pages 55-61

  Parmar, Komal R ^a   Shah, Sunny R ^a   Sheth, Navin R ^a  

^a SAURASHTRA UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EZETIMIBE; GELUCIRE; LACTOSE; MACROGOL 4000; MACROGOL 6000;

ADSORPTION; ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; MATHEMATICAL MODEL; PHYSICAL CHEMISTRY; SURFACE PROPERTY; X RAY DIFFRACTION;

EID: 80052768286     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT180311P55     Document Type: Article

References (23)

1. Deepti, D. H; Madan, A. K. Solid dispersion adsorbates for enhancement of dissolution rates of drugs. PDA J. Pharm. Sci. Technol. 2007, 61 (2), 97-101.
2. Gupta, M. K.; Goldman, D.; Bogner, R. H.; Tseng, Y. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharm. Dev. Technol. 2001, 6 (4), 563-572.
3. Patel, R. P.; Patel, M. M. Physicochemical characterization and dissolution study of solid dispersions of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm. Dev. Technol. 2007, 12 (1), 21-33.
4. Van den Mooter, G.; Augustijns, P.; Blaton, N.; Kinget, R.Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 1998, 164 (1-2), 67-80.
5. Tashtoush, B. M.; Al-Qashi, Z. S.; Najib, N. M. In vitro and in vivo evaluation of glibenclamide in solid dispersion systems. Drug Dev. Ind. Pharm. 2004, 30 (6), 601-607.
6. Kosoglou, T.; Statkevich, P.; Johnson-Levonas, A. O.; Paolini, J. F.; Bergman, A. J.; Alton, K. B. Ezetimibe: a review of its metabolism, pharmacokinetics and drug interactions. Clin. Pharmacokinet. 2005, 44 (5), 467-494.
7. Dixit, R. P.; Nagasenker, M. S. Self-nanoemulsifying granules of ezetimibe: design, optimization and evaluation. Eur. J. Pharm. Sci. 2008, 35 (3), 183-192.
8. Patel, R.; Bhimani, D.; Patel, J.; Patel, D. Solid-state characterization and dissolution properties of ezetimibe-cyclodextins inclusion complexes. J. Incl. Phenom. Macro. 2008, 60 (3-4), 241-251.
9. Pore, Y. V., Sancheti, P. P.; Karekar, P.; Vyas, V. M.; Shah, M. Preparation and physicochemical characterization of surfactant based solid dispersions of ezetimibe. Pharmazie 2009, 64 (4), 227-231.
10. Higuchi, T.; Connors, K. A. Phase-solubility techniques. Adv. Anal. Chem. Instr. 1965, 4, 117-212.
11. U.S. Food and Drug Administration. FDARecommended Dissolution Methods database. http://www.accessdata.fda.gov/scripts/cder/dissolution/dsp_SearchResults_Dissolutions.cfm(accessed July 20, 2011).
12. Ahuja, N.; Katare, O. P.; Singh, B. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using watersoluble carriers. Eur. J. Pharm. Biopharm. 2007, 65 (1), 26-38.
13. O'Hara, T.; Dunne, A.; Butler, J.; Devane, J. A review of methods used to compare dissolution profile data. Pharm. Sci. Technol. To. 1998, 1 (5), 214-223.
14. Cirri, M.; Mura, P.; Rabasco, A. M.; Gines, J. M.; Moyano, J. R.; Gonzalez-Rodriguez, M.L. Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers. Drug Dev. Ind. Pharm. 2004, 30 (1), 65-74.
15. Zerrouk, N.; Chemtob, C.; Arnaud, P.; Toscani, S.; Dugue, J. In vitro and in vivo evaluation of carbamazepine- PEG 6000 solid dispersions. Int. J. Pharm. 2001, 225 (1-2), 49-62.
16. Barker, S. A.; Yap, S. P.; Yuen, K. H.; McCoy, C. P.; Murphy, J. R.; Craig, D. Q. M. An investigation into the structure and bioavailability of α-tocopherol dispersions in Gelucire 44/14. J. Controlled Release 2003, 91 (3), 477-488.
17. Damian, F.; Blaton, N.; Naesens, L.; Balzarini, J.; Kinget, R.; Augustijns, P.; Van den Mooter, G. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. 2000, 10 (4), 311-322.
18. Shinde, V. R.; Shelake, M. R.; Shetty, S. S.; Chavan-Patil, A. B.; Pore, Y. V.; Late, S. G. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique. J. Pharm. Pharmacol. 2008, 60 (9), 1121-1129.
19. Costa, P.; Sousa Lobo, J. M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 2001, 13 (2), 123-133.
20. Bashiri-Shahroodi, A.; Nassab, P. R.; Szabó-Révész, P.; Rajkó, R. Preparation of a Solid Dispersion by a Dropping Method to Improve the Rate of Dissolution of Meloxicam. Drug Dev. Ind. Pharm. 2008, 34, 781-788.
21. Ruan, L. P.; Yu, B. Y.; Fu, G. M.; Zhu, D. N. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal. 2005, 38 (3), 457-464.
22. Chidaveaenzi, O. C.; Buckton, G.; Koosha, F. The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose. Int. J. Pharm. 2001, 216 (1-2), 43-49.
23. Passerini, N.; Albetini, B.; Gonzales-Rodriguez, M. L.; Cavallari, C.; Rodriguez, L. Preparation and characterisation of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur. J. Pharm. Sci. 2002, 15 (1), 71-78.